Former scientists, chemists, patent examiners and chemical engineers comprise our biotechnology team. This diverse technical experience helps our clients navigate the competitive and evolving industry. As extensions of our clients’ inside counsel, we always keep an eye toward the future, diligently preparing for any potential patent enforcement or licensing challenge.
From genetically engineered enzymes and biosynthetic methods to diagnostic methods and bioremediation, we’re at the forefront of industry developments. We’re constantly creating and enhancing litigation strategies for the new biosimilars legislation and regulations. And in addition to litigation, we have extensive experience in complex licensing and patent technology as well as M&A IP due diligence for the chemistry, pharmaceutical and biotechnology industries.
Our attorneys are frequently acknowledged for their biotechnology work by the National Law Journal and Chambers USA. What’s more, courts have cited many of our published articles, and we’ve even received the “Burton Award for Best Law Firm Publication.”
